4.3 Article

Probiotic potential of Weissella paramesenteroides MYPS5.1 isolated from customary dairy products and its therapeutic application

Journal

3 BIOTECH
Volume 12, Issue 1, Pages -

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s13205-021-03074-2

Keywords

Probiotics; Dairy products; Exopolysaccharides; Weissella paramesenteroides; Biofilm; Bile tolerance; Lactic acid bacteria; Antitumor

Funding

  1. BHU, Varanasi [F(C)/XVIII-Spl. Fund/Misc/Infrastructure/Instt. Sc/2019-2020/10290]
  2. DBT, Govt. of India at the School of Biotechnology, Banaras Hindu University, Varanasi, India
  3. Department of Science and Technology, New Delhi [1196 SR/FST/LS-I/2017/4]
  4. Department of Biotechnology, Government of India [BT/PR27437/BCE/8/1433/2018]
  5. M.D. University, Rohtak, India

Ask authors/readers for more resources

This study focused on isolating potential probiotic strains from dairy products. Among the isolated strains, strain MYPS5.1 of Weissella paramesenteroides was identified as the best candidate with potential therapeutic properties. This strain exhibited antibiotic resistance and produced a high concentration of exopolysaccharide. It also showed interaction with cyclin-dependent kinase, which is thought to play a role in cancer pathogenesis.
Probiotics are viable microorganisms that confer general health benefits to the host when consumed in an adequate concentration. Probiotics may also possess strain-specific therapeutic properties and therefore finding novel strains with probiotic properties is becoming increasingly important. The present study has focused on the isolation of probiotic bacteria from dairy products which possessed potential therapeutic properties. Of the 79 strains isolated, eight were selected for further studies based on a number of traits including biofilm formation, deoxyribonuclease (DNase) activity, agglutination activity, auto-aggregation activity, antibiotic resistance, and antagonistic activity. Strain MYPS5.1 was selected from the eight isolates as the best potential probiotic candidate strain and was subsequently identified as Weissella paramesenteroides by 16S rDNA gene sequencing and sequence analysis. W. paramesenteroides strain MYPS5.1 was resistant to a number of antibiotics and the strain produced a high concentration of exopolysaccharide (EPS) (380.42 mg/L). The functional groups C-H, C = C, N = N, N-H, and C-O in the EPS were identified by using Fourier transform infrared (FTIR) spectroscopy. Computational studies showed that it interacted with cyclin-dependent kinase (CDK), a molecule which is thought to play a role in cancer pathogenesis (REF). Collectively, these results suggest that Weissella paramesenteroides MYPS5.1 is a potential probiotic strain with potential therapeutic properties.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available